Assembly Biosciences is advancing its herpes drug to Phase II trials after it showed 94% antiviral efficacy in a Phase Ib ...

A modified herpes virus (RP1) combined with immunotherapy showed promising results against advanced melanoma in a clinical ...

Assembly Biosciences, Inc.'s ABI-5366 showed strong interim phase 1b results in HSV-2 recurrent genital herpes patients.

The herpes simplex virus type 1 (HSV-1), the virus that causes cold sores, tend to break out around the mouth but more people are getting diagnosed with HSV-1 around their genitalia.

And other herpes viruses, like the ones that cause chickenpox, shingles, and human herpes virus 6, have also been linked to the onset and worsening of MS, which affects 1 million Americans.

The herpes simplex virus is very common and up to 80 percent of Swedish adults may be infected. The infection is lifelong, but the symptoms can come and go over different periods of life.

Mounting evidence suggests that herpes simplex virus 1 may be associated with an increased risk for Alzheimer’s disease and dementia, according to a systematic review of published studies ...

If you are looking for an effective lysine supplement for genital herpes, Bronson L-Lysine Defense Immune Support Complex is a great choice. Pros L-Lysine helps to maintain healthy production of L ...

The global herpes simplex virus treatment market is expected to grow from $2.1 billion in 2022 to $2.24 billion in 2023 at a compound annual growth rate (CAGR) of 6.6%. The Russia-Ukraine war ...

Harmol's anti-HSV-1 effect was confirmed by measuring Glycoprotein D of Herpes Simplex Virus Type 1 (gD-1) protein expression. Both ACV (1 µM) and harmol (0-50 µM) reduced HSV-1 gD-1 protein levels.

Herpes simplex virus-1 (HSV-1), it turns out, also redecorates, according to a new study in Nature Communications. Researchers at the Centre for Genomic Regulation (CRG) in Barcelona have discovered ...

First off, a person with herpes simplex virus type 1 (about half of the population between ages 18-49, higher in older people) or HSV-2 (about 12 per cent of the same population) certainly can ...